In this review
A named vial is a useful comparison point
Nova’s NAD+ page identifies a ready-to-use 10 mL injection vial at 100 mg/mL. Sermorelin is described as 15 mg in a 5 mL vial at 3 mg/mL. Both product descriptions name an under-the-skin route and provider review. These details help identify what is offered without proving an effect on aging or verifying a particular dispensed batch. [1] [2]
The actual prescription still needs ingredients, vial count, dispensing pharmacy and the supplied period. The policy expressly says a monthly billing schedule does not automatically establish thirty days of medication. Do not build a yearly cost or a treatment result from the vial label alone. [3]
Separate a measurement from a meaningful health outcome with the biological-age testing evidence.
Each service has its own bill
NAD+ is $149 monthly or $345 quarterly; sermorelin is $149 monthly or $315 quarterly. The lower $115 and $105 figures are monthly equivalents of quarterly charges. The product tabs say quarterly shipments accompany those plans. Neither price is a membership covering the wider catalogue. [1] [2] [4]
Semaglutide and tirzepatide are separate purchases. Tirzepatide’s pharmacy choices differ in price, additives and state restrictions, and its policy permits a pharmacy change when production pauses. A broader platform does not make the preparations interchangeable or guarantee continuity with one dispenser. [3] [5]
Keep each preparation and bill separate in the health-service cost planner.
Included access is not an annual health review
The pages describe consultation, supplies, delivery, chat and follow-ups. The terms distinguish the access platform from independent clinicians and dispensing pharmacies. That is an arrangement for a selected prescription, not evidence of an included preventive examination, full annual laboratory panel or specialist appointment calendar. [1] [2] [6]
I would compare the clinical purpose and actual monitoring before a monthly price. A cellular-health or recovery theme cannot tell the reader which tests are warranted or whether adding another product helps. Compounded drugs are not FDA-approved, and a supplied formulation needs its own clinical justification. [7]
Compare another catalogue and clinical-access model in our LaSara service-scope review.
Compare another prescription service with a different cancellation boundary in our Näky care-and-commitment review.
Financial flexibility ends earlier than the parcel arrives
The refund policy captures payment after approval and releases the hold on non-approval. An approved cancellation before pharmacy filling may retain $25 for the completed consultation. Once filled, orders are generally final even if the customer cannot tolerate continuing. Future renewals need at least forty-eight hours’ cancellation notice. [3]
Timely unprocessed renewal requests, confirmed fulfillment problems and specified shipping delays have separate remedies. The delay wording uses both ten days and ten business days, so clarify the applicable rule. I would choose Nova for a clear prescription service and payment agreement, rather than prepay several treatments around a promise of healthier aging. [3]
For another prepaid service with conditional remedies, read the Telezen MD financial-commitment review.
Understanding the cost
NAD+ $149 monthly or $345 quarterly; sermorelin $149 monthly or $315 quarterly. Weight care separately $175 semaglutide/$199 tirzepatide monthly, with pharmacy-specific quarterly choices. No all-service package established. Confirm actual count, tests, shipment and renewal.
Build your cost estimateSources
- Try Nova MD: NAD+ vial specification, selected pricing/description tabs and route FAQ
- Try Nova MD: sermorelin vial content, selected pricing/description tabs and clinical service
- Try Nova MD: authorization, fulfillment, renewal, shipment and refund conditions
- Try Nova MD: current catalogue, selected plan controls and ongoing-support description
- Try Nova MD: selected tirzepatide pharmacy plans, formulations and state restrictions
- Try Nova MD: platform role, independent providers/pharmacies and cancellation terms
- FDA: compounded drugs and premarket approval limits
This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.